Reference
- Kok VC, et al. Successful remission of hemolytic-uremic syndrome during the third-line weekly gemcitabine for metastatic breast cancer. Breast Cancer: Basic and Clinical Research 8: 57-59, No. 1, 26 Mar 2014 - TaiwanGoogle Scholar
Copyright information
© Springer International Publishing Switzerland 2014